I see two option,
1. return back - should be checking out 2 values for comeback , 327.24 and 309.5.
2. breaking out that red line and 2 targets mentioned above.
Good luck to shareholders - not for any suggestion.
Shavoa tov - from Israel :)
RedHill plans to launch Talicia®1 in the U.S. in Q1/2020 for the treatment of H. pylori infection in adults,
targeting more than two million patients estimated to be treated for H. pylori infection annually
Talicia® is the first and only FDA approved rifabutin-based H. pylori therapy and is designed to address the high
and growing bacterial resistance and...